Clovis Oncology, Inc.
CLVS
CLVS was delisted on the 20th of December, 2022.
192 hedge funds and large institutions have $3.27B invested in Clovis Oncology, Inc. in 2015 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 88 increasing their positions, 45 reducing their positions, and 24 closing their positions.
96% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 45
71% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 24
18% more capital invested
Capital invested by funds: $2.76B → $3.27B (+$507M)
9% more funds holding
Funds holding: 176 → 192 (+16)
0% more funds holding in top 10
Funds holding in top 10: 13 → 13 (0)
4% less call options, than puts
Call options by funds: $49.6M | Put options by funds: $51.5M
Top Buyers
| 1 |
AA
Antipodean Advisors
New York
|
+$113M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$72.4M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$61.2M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$52.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$36.1M |
Top Sellers
CLVS Hedge Fund Activity: Q3 2015 in Review
192 of the 3,581 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q3 2015, worth a combined $3.27B — up 18% from $2.76B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new CLVS positions and 24 closed out — a net gain of 17 holders — while 88 added to existing stakes and 45 trimmed.
The largest buyer was Antipodean Advisors, opening a new position worth an estimated $113M. The largest seller was Lord, Abbett & Co, cutting an estimated $50.3M.
- 192 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q3 2015, up from 176 in Q2 2015.
- Funds reported $3.27B of Clovis Oncology, Inc. stock for Q3 2015, up 18% quarter-over-quarter.
- 41 funds opened new Clovis Oncology, Inc. positions in Q3 2015 and 24 closed out, a net change of +17 holders.
- The largest Clovis Oncology, Inc. buyer in Q3 2015 was Antipodean Advisors, an estimated $113M added.
- The largest Clovis Oncology, Inc. seller in Q3 2015 was Lord, Abbett & Co, an estimated $50.3M sold.
Based on aggregated 13F filings for Q3 2015.